Details
Title
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Author
Boshuizen, Julia 1
; Vredevoogd, David W. 1
; Krijgsman, Oscar 1 ; Ligtenberg, Maarten A. 1 ; Blankenstein, Stephanie 2 ; de Bruijn, Beaunelle 1 ; Frederick, Dennie T. 3 ; Kenski, Juliana C. N. 1 ; Parren, Mara 1
; Brüggemann, Marieke 1 ; Madu, Max F. 2 ; Rozeman, Elisa A. 1 ; Song, Ji-Ying 4 ; Horlings, Hugo M. 5
; Blank, Christian U. 1
; van Akkooi, Alexander C. J. 2 ; Flaherty, Keith T. 6
; Boland, Genevieve M. 3
; Peeper, Daniel S. 1
1 The Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Oncode Institute, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
2 The Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
3 Massachusetts General Hospital, Department of Surgical Oncology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
4 The Netherlands Cancer Institute, Division of Animal Pathology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
5 The Netherlands Cancer Institute, Division of Pathology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
6 Massachusetts General Hospital, Department of Medical Oncology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
; Vredevoogd, David W. 1
; Krijgsman, Oscar 1 ; Ligtenberg, Maarten A. 1 ; Blankenstein, Stephanie 2 ; de Bruijn, Beaunelle 1 ; Frederick, Dennie T. 3 ; Kenski, Juliana C. N. 1 ; Parren, Mara 1
; Brüggemann, Marieke 1 ; Madu, Max F. 2 ; Rozeman, Elisa A. 1 ; Song, Ji-Ying 4 ; Horlings, Hugo M. 5
; Blank, Christian U. 1
; van Akkooi, Alexander C. J. 2 ; Flaherty, Keith T. 6
; Boland, Genevieve M. 3
; Peeper, Daniel S. 1
1 The Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Oncode Institute, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
2 The Netherlands Cancer Institute, Division of Surgical Oncology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
3 Massachusetts General Hospital, Department of Surgical Oncology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
4 The Netherlands Cancer Institute, Division of Animal Pathology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
5 The Netherlands Cancer Institute, Division of Pathology, Amsterdam, The Netherlands (GRID:grid.430814.a) (ISNI:0000 0001 0674 1393)
6 Massachusetts General Hospital, Department of Medical Oncology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
Pages
672
Publication year
2023
Publication date
2023
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2774005858
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.